Literature DB >> 24630567

Does the evidence say a 4-point change in ADAS-cog score is clinically significant?

Mark Oremus1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24630567     DOI： 10.1016/j.jalz.2013.12.017

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN： 1552-5260            Impact factor:   21.566


× No keyword cloud information.
  4 in total

Review 1.  Cholesterol, statins, and dementia: what the cardiologist should know.

Authors:  Brett L Wanamaker; Kristopher J Swiger; Roger S Blumenthal; Seth S Martin
Journal:  Clin Cardiol       Date:  2015-04-13       Impact factor: 2.882

2.  Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial.

Authors:  Victor W Henderson; Tom Ala; Kristin L Sainani; Allan L Bernstein; B Sue Stephenson; Allyson C Rosen; Martin R Farlow
Journal:  Neurology       Date:  2015-11-04       Impact factor: 9.910

3.  Outcomes of a multimodal cognitive and physical rehabilitation program for persons with mild dementia and their caregivers: a goal-oriented approach.

Authors:  Justin Chew; Mei-Sian Chong; Yoke-Leng Fong; Laura Tay
Journal:  Clin Interv Aging       Date:  2015-10-22       Impact factor: 4.458

4.  Association between serum non-high-density lipoprotein cholesterol and cognitive impairment in patients with acute ischemic stroke.

Authors:  Da Lu; Pan Li; Yuying Zhou; Xiaolin Xu; Huihong Zhang; Liping Liu; Zhiyan Tian
Journal:  BMC Neurol       Date:  2016-08-26       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.